Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
fig.5.k, l
Agüero TH et al. (2012) |
Xla Wt + alpha-3000:ihh
NF16 (in situ hybridization) |
|
||||||
fig.5.a
Agüero TH et al. (2012) |
Xla Wt + ihh
NF16 (in situ hybridization) |
|
||||||
fig.5.b
Agüero TH et al. (2012) |
Xla Wt + ihh
NF16 (in situ hybridization) |
|
||||||
fig.5.c
Agüero TH et al. (2012) |
Xla Wt + ihh
NF16 (in situ hybridization) |
|
||||||
fig.5.d
Agüero TH et al. (2012) |
Xla Wt + ihh
NF16 (in situ hybridization) |
|
||||||
fig.5.i
Agüero TH et al. (2012) |
Xla Wt + ihh
NF16 (in situ hybridization) |
|
||||||
fig.3.g
Agüero TH et al. (2012) |
Xla Wt + ihh MO
NF16 (in situ hybridization) |
|
||||||
fig.3.h
Agüero TH et al. (2012) |
Xla Wt + ihh MO
NF16 (in situ hybridization) |
|
||||||
fig.3.i, k
Agüero TH et al. (2012) |
Xla Wt + ihh MO
NF16 (in situ hybridization) |
|
||||||
fig.3.j, k
Agüero TH et al. (2012) |
Xla Wt + ihh MO
NF16 (in situ hybridization) |
|